Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
69,567,929
-
Share change
-
+1,159,120
-
Total reported value
-
$8,000,351,953
-
Put/Call ratio
-
147%
-
Price per share
-
$114.94
-
Number of holders
-
343
-
Value change
-
-$105,940,386
-
Number of buys
-
201
-
Number of sells
-
205
Institutional Holders of SALIX PHARMACEUTICALS INC - COM (SLXP) as of Q4 2014
As of 31 Dec 2014,
SALIX PHARMACEUTICALS INC - COM (SLXP) was held by
343 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,567,929 shares.
The largest 10 holders included
PAULSON & CO INC, VANGUARD GROUP INC, Visium Asset Management, LP, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., Viking Global Investors LP, Invesco Ltd., JANUS CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
343
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.